Skip to Main Content

Yale Psychiatry Grand Rounds: May 14, 2021

 .

Yale Psychiatry Grand Rounds: May 14, 2021

May 14, 2021

"Contemporary Issues in the Regulation of Tobacco Products"

Suchitra Krishnan-Sarin, PhD, Professor of Psychiatry, Yale School of Medicine

ID
6592

Transcript

  • 00:00As well as those of you who
  • 00:03were listening on just heard,
  • 00:06we have three incredible presentations
  • 00:08coming up in the next three weeks.
  • 00:13Next week is the inaugural.
  • 00:17The first of two inaugural lectures
  • 00:20that have been endowed by an alumnus
  • 00:24of our Department named Byram.
  • 00:26Karasu, Doctor Karasu was a
  • 00:29longtime chair of psychiatry
  • 00:32at Einstein School of Medicine.
  • 00:35And very active in in the in the American
  • 00:40Psychiatric Association and other places an.
  • 00:44That has endowed one lecture,
  • 00:46the first of which will be next
  • 00:48week in the second lecture,
  • 00:50which we hope to hold over this summer.
  • 00:52The first lecture is related to.
  • 00:57Psychotherapy the humanities.
  • 01:02And and sort of a more humanistic
  • 01:05aspects of psychiatry and to kick
  • 01:08off that lecture we have urban
  • 01:10yellow who as you know is both a
  • 01:14leading psychotherapy researcher
  • 01:15from Stanford and also a novelist.
  • 01:18In case any of you have read any of his
  • 01:22novels, including when I read about it,
  • 01:26a murder set around a psychoanalytic
  • 01:28Institute. Fun, fun, read.
  • 01:32Anyway, so so we will watch and
  • 01:35edited interview conducted by David
  • 01:37Ross of Irving Yellow next week.
  • 01:39Then you have the opportunity to discuss
  • 01:42it and that should be a lot of fun.
  • 01:46Yellow is obviously one of the
  • 01:49great leaders in psychotherapy.
  • 01:51Of his generation in our time.
  • 01:55The following week is the last minute
  • 01:57word lecture and the Lustman awardee's,
  • 01:59literally in the 10 minutes
  • 02:01before this lecture,
  • 02:02just received their notifications
  • 02:03of words so they will have as much
  • 02:06time to prepare their lecture
  • 02:07as I will have to prepare the
  • 02:10state of Department lecture,
  • 02:11which is going to be the
  • 02:13following week on June 4th and
  • 02:15which I'm looking forward to.
  • 02:19But today's lecture is a special a
  • 02:23special lecture for us, and our lecture
  • 02:28is Professor Suchitra Krishnan Sarin.
  • 02:31She's obviously a professor in
  • 02:34our Department and chair of one
  • 02:37of the IRB committees at Yale.
  • 02:39She got her bachelor's degree in India,
  • 02:42then PhD in pharmacology at Purdue,
  • 02:45and then she came to Yale 1994
  • 02:48to pursue addiction research,
  • 02:50training, and the rest.
  • 02:52As they say, is history.
  • 02:56You know she's really been
  • 02:58a pioneer in so many areas.
  • 03:01One of the most important areas
  • 03:04where she's really had an enormous
  • 03:06impact has been in trying to
  • 03:09understand and develop treatments
  • 03:11for addictions in adolescence,
  • 03:14particularly adolescent smoking and
  • 03:16and her development of research in that
  • 03:19area coincided with the emergence of vaping,
  • 03:22the so-called safe alternative to smoking,
  • 03:25which turns out not to be.
  • 03:29So safe and so in two large major
  • 03:35national initiatives that that Doctor
  • 03:40Krishnan Sarin is led with with.
  • 03:45Stephanie O'Malley and other
  • 03:46faculty in the Department, the.
  • 03:51The teacher can now the transdisciplinary
  • 03:53regulation Smoking Regulation
  • 03:54Center for regulatory science.
  • 03:55I knew it.
  • 03:56It's going to need to look
  • 03:58at it to get the name right.
  • 04:04Sojitra has really led an important
  • 04:07initiative to both understanding intervene
  • 04:10in adolescent smoking and vaping,
  • 04:12but also to understand and better inform
  • 04:16the regulatory process and the payoff
  • 04:20of their work and that of others has
  • 04:23had enormous impact on public health.
  • 04:26It's no accident, for example,
  • 04:29that the FDA banned.
  • 04:33Inclusion of menthol in cigarettes,
  • 04:36which is a remarkable remarkable
  • 04:40statement about the FDA's awareness about
  • 04:44how various aspects besides nicotine,
  • 04:48can drive addiction,
  • 04:50and particularly in in
  • 04:54vulnerable populations. Anne.
  • 04:57Although her lecture today is
  • 05:00not going to focus on this,
  • 05:02she's contributed to many other areas,
  • 05:05and in particular for me have been
  • 05:07a really important valued can key
  • 05:10investigator in our in IEEE supported
  • 05:12Center for the translational
  • 05:14neuroscience of alcoholism,
  • 05:16where she's LED projects in the in the
  • 05:19laboratory studying the pharmacology
  • 05:21of Alcohol Self Administration,
  • 05:23which is really been been
  • 05:25fascinating and informative.
  • 05:27So she should also leads an American
  • 05:31Heart Association funded center in
  • 05:33addition to as if that wasn't enough,
  • 05:36the American Heart Association funded Center,
  • 05:39which is developing youth focus prevention
  • 05:42and cessation interventions for E
  • 05:44cigarettes and tobacco use behavior,
  • 05:46and she's really been an extremely
  • 05:50productive investigator with
  • 05:51over 217 research publications.
  • 05:54As I alluded to in talking
  • 05:57about the impact of her work,
  • 05:59Suchitra is really been an important
  • 06:01national leader in the area of smoking.
  • 06:04She's been involved in several
  • 06:06Surgeon General's reports,
  • 06:07an adult and youth tobacco use behaviors.
  • 06:10She served as a member of the FDA's
  • 06:12Tobacco Product Scientific Advisory
  • 06:14Committee on the CDC's Interagency
  • 06:16Committee on Smoking and Health,
  • 06:18led by the Surgeon General,
  • 06:20and she's been involved
  • 06:22in other organizations.
  • 06:23A consultant to the Tobacco Free Initiative
  • 06:25of the World Health Organization.
  • 06:28She for 20 to 21 has been president of the
  • 06:32Society for Research on Nicotine and Tobacco.
  • 06:37She plays editorial roles in three journals,
  • 06:41including including being a senior
  • 06:44editor of Tobacco Regulatory Science,
  • 06:46and she's also been incredibly
  • 06:49public spirited,
  • 06:50involved in educational initiatives,
  • 06:53community initiatives doing
  • 06:55doing a Ted Med Talk.
  • 06:58A really somebody who is not just
  • 07:01generating the research but but paying
  • 07:04it back to in ways that that have
  • 07:07an important effect on our community
  • 07:09on our educational environment.
  • 07:11In our research community.
  • 07:13Through her role in the hics so so teacher,
  • 07:17I want to acknowledge your very special
  • 07:20contributions not only as an investigator,
  • 07:22but also as a leader and and
  • 07:25how much we appreciate that.
  • 07:27So without further ado.
  • 07:29Please take it away and tell us about
  • 07:32the advances in regulatory regulation.
  • 07:35You thank you.
  • 07:36Thank you,
  • 07:36John.
  • 07:37Thank you
  • 07:38for that very very kind and
  • 07:40very nice invitation unblushing.
  • 07:41In case you can see it on screen.
  • 07:44But that was that was really very nice I've.
  • 07:47I think one of the things I always
  • 07:50tell people is that I enjoy every
  • 07:53little bit of what I do and I enjoy
  • 07:56the signs that comes with it so it
  • 07:59makes life interesting and exciting.
  • 08:01So let me share my screen here.
  • 08:04And well, I'm already at the bottom sorry,
  • 08:07I just did a run through my slides.
  • 08:17OK can you see my slides now?
  • 08:20Trisha yes yes alright so.
  • 08:23So like John said,
  • 08:24I do a lot of work in the tobacco
  • 08:27area as well as in the alcohol area.
  • 08:30I'm not going to talk about the
  • 08:32alcohol area today and I really
  • 08:34thought I would give you a flavor
  • 08:36for what we're doing and some very
  • 08:39contemporary issues in tobacco
  • 08:40regulation which are coming up.
  • 08:44You know today and over the next few
  • 08:47months in state legislatures as well as
  • 08:52federale legislatures for consideration.
  • 08:55Just start out just to let you all
  • 08:57know that I and this is always a
  • 09:00very important issue for anybody
  • 09:01working in the field of tobacco.
  • 09:03To acknowledge that I do not have
  • 09:05any tobacco industry funding and
  • 09:07all everything I'll be talking
  • 09:09about is funded through NIH or FDA.
  • 09:15Scoop up, take a so the basics basic
  • 09:18problem are why this issue of tobacco
  • 09:21regulation become became very important,
  • 09:24as probably many of you know is
  • 09:27because of the cigarette epidemic.
  • 09:29You know cigarette consumption went
  • 09:32up significantly after the World Wars
  • 09:35in in the US and all over the world.
  • 09:38A commercial cigarette consumption.
  • 09:40And as this graph clearly shows,
  • 09:42there were a lot of regulatory.
  • 09:46Not a lot of laws and other kinds
  • 09:48of mechanisms that were put into
  • 09:49place in the US to try and stem this
  • 09:52increase in cigarette consumption.
  • 09:53And you see,
  • 09:54some of those listed on this slide.
  • 09:57Now, despite all this,
  • 09:58there are still people who smoke
  • 10:00cigarettes and smoke quite a lot,
  • 10:02and therefore one of the things the
  • 10:04FDA had been trying to do for a very
  • 10:07long time was to get the authority
  • 10:09to actually regulate the components
  • 10:11of the constituents of cigarettes so
  • 10:13that they could make it safe for use.
  • 10:16Because the tobacco industry has been
  • 10:18known over the years to manipulate
  • 10:20the content contents of these products
  • 10:22to make them more addictive and get
  • 10:24more people using these products
  • 10:26and addicted to these products.
  • 10:28And as you know,
  • 10:29as we all know,
  • 10:31cigarette consumption are cigarette.
  • 10:32Smoking is still one of the biggest public
  • 10:35health problems in the US and worldwide.
  • 10:38So in 2009,
  • 10:39President Obama signed what's
  • 10:40called the Family Smoking
  • 10:42Prevention and Tobacco Control Act,
  • 10:44and this act gave the FDA the authority for
  • 10:47the first time to regulate the manufacture,
  • 10:50distribution and marketing
  • 10:51of tobacco products.
  • 10:52Now I have underlying manufacturer
  • 10:54here because that is what was
  • 10:57really a key feature of this act.
  • 10:59The distribution and marketing
  • 11:01was something that was already
  • 11:02being controlled by various laws,
  • 11:04but the FDA never had any control over
  • 11:07what actually went into a cigarette,
  • 11:09and this is since 2009 they
  • 11:11have had that authority.
  • 11:12That's when they got this authority.
  • 11:14They realized that they had very little
  • 11:16signs to support how to do this work.
  • 11:19Like how do we regulate it?
  • 11:21What level of nicotine is safe?
  • 11:23What level of what pH is safe?
  • 11:25What?
  • 11:25How can we make the product less addictive?
  • 11:28So on and so forth?
  • 11:30So many questions that they had.
  • 11:32They did not know how to do it,
  • 11:35so they decided to come up with a
  • 11:37comprehensive plan for how they would
  • 11:39approach tobacco and nicotine regulation.
  • 11:41And some of these are listed on the slide.
  • 11:44They really wanted to have
  • 11:46regulatory policies on addiction,
  • 11:47appeal and sensation and assigned
  • 11:49space review of all tobacco products
  • 11:51and a youth tobacco prevention plan.
  • 11:53These are the three key features
  • 11:55of this comprehensive plan that the
  • 11:58FDA has and from investigators.
  • 11:59What they really want.
  • 12:01You know, was how do we implement this?
  • 12:04How do we go about doing this so
  • 12:06they look for and occasionally
  • 12:08they will come out and tell us we
  • 12:11are looking for evidence on this
  • 12:13or this particular
  • 12:14issue and we as a tobacco center are
  • 12:16will will put our efforts into creating
  • 12:19that scientific evidence to support
  • 12:21whatever legal course they're taking.
  • 12:23And some of the things that they highlighted
  • 12:25in what they were interested in,
  • 12:28was it dramatical product,
  • 12:29standard for nicotine levels
  • 12:31in combustible cigarettes so?
  • 12:32The question they had is it can be lower
  • 12:35the levels of nicotine in cigarettes,
  • 12:37straight minimal or non addictive
  • 12:39level and created a product nicotine
  • 12:41standard which would decrease the
  • 12:43addictive potential of these products.
  • 12:45Another issue that they were very
  • 12:47interested in was the regulation of
  • 12:49flavors in tobacco products and they
  • 12:52continue to this day try to figure
  • 12:54out how to regulate these product.
  • 12:56So what I'm going to go through
  • 12:58over the next few slides is tell
  • 13:01you a little bit about.
  • 13:03What's going on in each of these areas?
  • 13:06And then also tell you as about E
  • 13:09cigarettes and what the public health
  • 13:11debate around this is and what scientific
  • 13:14evidence we have for this product.
  • 13:16So anyway,
  • 13:17in order to do this,
  • 13:19generate all the scientific
  • 13:21evidence the FT established tobacco
  • 13:23Center of regulatory science,
  • 13:24and that's what you see on this slide here.
  • 13:28These are. There are nine centers.
  • 13:30This is actually the second iteration.
  • 13:33In the first situation,
  • 13:34there were 14 centers,
  • 13:35and then nine were renewed for
  • 13:38another five years and we were
  • 13:40fortunate to be one of the ones
  • 13:42that was ripped that were renewed.
  • 13:44And this is this shows you where the
  • 13:46nine centers are in the US as far as the
  • 13:49year Tobacco Center of Regulatory Science,
  • 13:52our goal is to really examine how
  • 13:54the constituents and characteristics
  • 13:55of tobacco products alter appeal.
  • 13:57Addictive potential use behaviors
  • 13:58and toxicity of these products.
  • 14:00So really generate the science to support.
  • 14:03If you're religious.
  • 14:05This is a very busy slide,
  • 14:07but this is Anna probably
  • 14:08missing a few people here,
  • 14:10but there are.
  • 14:10This is everyone who's involved
  • 14:12in our tobacco center so far,
  • 14:14and they have all made amazing
  • 14:16contributions to the field so far
  • 14:18and I will be showing you some data
  • 14:20from any of these individuals.
  • 14:22Throughout my talk.
  • 14:25So the first issue is that of flavors.
  • 14:31For those of you who have
  • 14:32smoked or use any black product,
  • 14:35you know that flavors exist in almost
  • 14:37every tobacco product on the market.
  • 14:39You see here, Flavors in their
  • 14:41flavors and in cigarettes.
  • 14:43There are flavors in smokeless tobacco
  • 14:45in cigars cigarillos which you see
  • 14:48on the left hand side here and then
  • 14:50also of course now in E cigarettes
  • 14:52which have over 15,000 flavors.
  • 14:54So flavors are an important
  • 14:56component of most tobacco products,
  • 14:58and the thought is that.
  • 14:59Flavors in some way make the product
  • 15:02more palatable and more easy to use,
  • 15:05so the inclusion of flavors is
  • 15:07not by accident or something which
  • 15:09Michael industry purposefully
  • 15:11introduced into products.
  • 15:12Now flavored tobacco products
  • 15:14are also very important,
  • 15:16as you can see here on this is the
  • 15:19proportion of current tobacco product
  • 15:21users who report using flavored products,
  • 15:24and they seem to be very important
  • 15:26from an initiation perspective.
  • 15:28There people were starting use of these.
  • 15:31Products really need the flavors to help
  • 15:34them get through the initial irritant.
  • 15:36Effects of tobacco are that tobacco
  • 15:39nicotine produces in your throat.
  • 15:41They also seem to be important
  • 15:44for continuing the diction and
  • 15:47preventing people from quitting.
  • 15:50Nine,
  • 15:502009 there was a statutory ban on all
  • 15:53flavors and cigarettes other than mental.
  • 15:56So cigarettes only combustible cigarettes
  • 15:58have not had flavors since 2009,
  • 16:00but menthol is still existed
  • 16:03in these products.
  • 16:05There has been a lot of moves
  • 16:07along with reports created by the
  • 16:09safety community asking the FDA
  • 16:10to remove mental from cigarettes.
  • 16:13For example,
  • 16:13the FDS tobacco product
  • 16:15Scientific advisory committee.
  • 16:16This was before I served on the committee.
  • 16:18They wrote a report and recommended
  • 16:20that removal of mental from the
  • 16:23marketplace would benefit public health
  • 16:25in the United States and they said
  • 16:27this based on a lot of evidence which
  • 16:29essentially I have tried to summarize here,
  • 16:31which showed that the presence of menthol
  • 16:34cigarettes and associated marketing.
  • 16:35Increased experimentation,
  • 16:36regular smoking,
  • 16:37especially among youth and African Americans,
  • 16:39that it increased addiction among
  • 16:41young people who smoke and the to
  • 16:44decrease the chances of smoking
  • 16:45cessation among African Americans who smoke.
  • 16:48Now,
  • 16:48why am I specifically talking about
  • 16:51African Americans?
  • 16:51It is pretty well known that the
  • 16:54tobacco industry has targeted different
  • 16:56populations for a very long time and in
  • 16:59the US there there have been very slow.
  • 17:02It's been very specific targeting
  • 17:04of specific populations and.
  • 17:06Two populations that stand out
  • 17:07our youth because they knew that
  • 17:09they could get them hooked young.
  • 17:11Then they would stay using their
  • 17:12products for a much longer period of
  • 17:15time and after the African American
  • 17:17population there have been very
  • 17:18specific ads like what you see here.
  • 17:20That have been used to target
  • 17:23this population,
  • 17:24and if you look at the left hand side
  • 17:26figure it shows you if you consider
  • 17:29just menthol cigarette use it shows
  • 17:31you menthol cigarette use among
  • 17:33different subgroups and you can see
  • 17:35that really the rates of use amongst
  • 17:38Blacks is the highest in the US.
  • 17:40This is evidence of very nice drive
  • 17:42put together by the truth initiative,
  • 17:44so this is a very important issue
  • 17:46because you have the industry
  • 17:48targeting a particular subgroup.
  • 17:50How do we counteract this?
  • 17:52Issue and how do we get rid of these mental
  • 17:55cigarettes so we don't get continue to
  • 17:58get people addicted to these products?
  • 18:01Now our center here retail has
  • 18:03done a lot of work to support,
  • 18:06provide more supports the
  • 18:08support of scientific evidence.
  • 18:10We have really focused on trying to
  • 18:12understand how does mentored really change
  • 18:15or make these products easier to use.
  • 18:18There wasn't so much evidence
  • 18:20earlier on this.
  • 18:21This is.
  • 18:22Animal work generated by Spaniard
  • 18:23and his group where they
  • 18:25looked at tobacco cigarettes.
  • 18:27Actually in animal models.
  • 18:29Looking at use of tobacco cigarettes
  • 18:31and then also use of E cigarette vapors.
  • 18:34You're welcome to that a little bit later,
  • 18:37but just focus on the left hand side
  • 18:40graph what you can see here is Ben.
  • 18:43Animals are given cigarettes that
  • 18:45contain just regular cigarettes
  • 18:46without menthol versus when they
  • 18:48contain in their given cigarettes.
  • 18:50With menthol there is a definite.
  • 18:53Change in the amount of time that
  • 18:55they hold their breath or breath.
  • 18:57Holding is basically called breaking
  • 18:59or how long the animal is the animal.
  • 19:02Find something irritating.
  • 19:03They hold their breath so when you when
  • 19:06you give them just regular smoke they
  • 19:08they hold their breath a lot longer.
  • 19:10But then when you give them
  • 19:12smoke that also contains mental.
  • 19:13So this basically tells you that
  • 19:15menthol is definitely altering
  • 19:17the irritating properties of
  • 19:18cigarette smoke in in animals.
  • 19:20And then there was this very
  • 19:22elegant study done by Christian.
  • 19:23Old in our center where she used
  • 19:26human experimental model to examine.
  • 19:29If you gave people who were mental
  • 19:31smokers and told them they could
  • 19:34only use non ventilated cigarettes.
  • 19:36I'm not presenting the entire
  • 19:38design to you here,
  • 19:40but essentially she recruited menthol
  • 19:42smokers and gave them only non menthol.
  • 19:45Same brand non menthol cigarettes to use.
  • 19:48And then she examined what happened
  • 19:51to their use behaviors and what
  • 19:53this clearly shows is when.
  • 19:55They are given the non menthol
  • 19:58cigarettes their cigarette smoking
  • 19:59actually goes down and so did
  • 20:01their dependence scores and they
  • 20:03also expressed interest in study
  • 20:05more interest in quitting smoking.
  • 20:07So this data tells you that removing
  • 20:09mental is definitely going to have
  • 20:11an impact on menthol smokers,
  • 20:13in that they're probably going
  • 20:15to decrease their smoking.
  • 20:16They they may also have decreased
  • 20:18independence and may want to have
  • 20:21increased interest in quitting smoking.
  • 20:23So this again just drives home the point,
  • 20:25how important the inclusion of menthol is.
  • 20:28Instagram's in fact there have
  • 20:30been some modeling studies that
  • 20:32have actually been done.
  • 20:33This is not work done in RT cores but
  • 20:36by other T course that show that the
  • 20:39prevalence of mental cigarettes may
  • 20:41actually have reduced the decline in
  • 20:44cigarette problems over the years.
  • 20:46And you see some numbers that they're
  • 20:49citing here on the right hand side,
  • 20:51they predict that that from 1980 to 2018,
  • 20:54menthol cigarettes were responsible
  • 20:56for reducing the decline in
  • 20:58cigarette prevalence by 2.6%.
  • 20:59And these are the number of extra smokers and
  • 21:03lives years lost because of the continued
  • 21:07presence of these products in the market.
  • 21:10So based on all this evidence,
  • 21:13a lot of countries have
  • 21:15banned menthol already,
  • 21:16and The Who has made a specific.
  • 21:20Put out a statement stating that
  • 21:23menthols should be banned by Paul.
  • 21:25Cigarettes should be banned and
  • 21:27the EU just banned the menthol
  • 21:30cigarettes in just in May 2022.
  • 21:32Now in the US the response
  • 21:36has been much lower the.
  • 21:39The in in in April 12,
  • 21:412013 because there was no
  • 21:44action in this on this issue,
  • 21:46there was a citizen's petition that
  • 21:49was filed asking the US FDA to stop
  • 21:53and remove mental from cigarettes.
  • 21:55This was put together by a lot of very
  • 21:59prominent health organizations in the US,
  • 22:02including the American Medical Association,
  • 22:04American Cancer Society, and the
  • 22:07Variety of American Heart Association.
  • 22:09But there was no movement and
  • 22:11based on that and June 17th,
  • 22:132020,
  • 22:13the FDA was sued over menthol cigarettes.
  • 22:16This was a suit put forward by the I'm sorry.
  • 22:19I don't mean glasses here because
  • 22:21I have a very small screen by the
  • 22:24American Tobacco Control Leadership
  • 22:25Council and the action on Smoking and
  • 22:28Health and they were joined in this
  • 22:30by a variety of other organizations
  • 22:32and they sued the FDA over their
  • 22:34lack of action on menthol cigarettes.
  • 22:36And the FDA actually had to provide
  • 22:39a comment.
  • 22:40Response to the suit by April 30th or
  • 22:42April 29th, I believe of this year,
  • 22:45which is what they did so the
  • 22:47Biden administration as you saw,
  • 22:49put out a statement stating that
  • 22:51they actually plan to remove
  • 22:52mental from cigarettes.
  • 22:54But I'll tell you this,
  • 22:55it's not that the story is not done here.
  • 22:58There's more to come because they're
  • 23:00still open to the issue of legal
  • 23:03action by the tobacco industry.
  • 23:04The tobacco industry can still
  • 23:06Sue them for this action,
  • 23:08and there's a lot of concern about.
  • 23:10A loss of revenue at the at the local level.
  • 23:14Mental cigarettes account for a huge
  • 23:16amount of sales in many communities.
  • 23:18And there's also concern about black market.
  • 23:21And while a scientist Sweet thinks
  • 23:23mentor should be removed from cigarettes,
  • 23:25one example of how this is these kind
  • 23:27of concerns are coming into place is
  • 23:30showing up in Connecticut itself.
  • 23:32Connecticut actually had a law they
  • 23:34were considering that they were
  • 23:36proposing to ban menthol cigarettes and
  • 23:38and a lot of flavors in E cigarettes.
  • 23:41And we just saw a different version
  • 23:43of the law there.
  • 23:45The menthol cigarette language
  • 23:46is actually been put aside and I
  • 23:49think this is based on the fact
  • 23:51that when this was presented to
  • 23:53the Connecticut legislature,
  • 23:54the issue of loss of revenue was
  • 23:57front and center and was proposed
  • 23:59to be pretty high and that may
  • 24:02have raised a lot of concerns,
  • 24:04but I would still say that removing
  • 24:06mentor from cigarettes is probably,
  • 24:08in my view a social justice
  • 24:10issue and it should happen.
  • 24:12And it should happen quickly.
  • 24:13But you know there is more
  • 24:15to come on this issue.
  • 24:20So I've talked a lot about
  • 24:21many flavors and cigarettes,
  • 24:22but what about other tobacco products, right?
  • 24:24So the cigarettes are not the only
  • 24:26tobacco product in the market.
  • 24:27There are a variety of others
  • 24:29now as far as the others,
  • 24:30the evidence is not so clear.
  • 24:32And why is that?
  • 24:34There is reason to be concerned
  • 24:36about use of other about flavors and
  • 24:38tobacco products because this is data
  • 24:41from a study called the Path study,
  • 24:43which the FDA and NIH grant,
  • 24:45which is a large student study looking at
  • 24:48tobacco use behaviors that started in 2013,
  • 24:50and this paper shows you that one of
  • 24:53the meeting reasons for non cigarette
  • 24:55trabocco product to use amongst past
  • 24:5830 day tobacco users in youth who
  • 25:00were 12 to 17 year olds was I used
  • 25:02the product because they come in.
  • 25:05Flavors and this applies across the board
  • 25:07for all different kinds of products,
  • 25:09ranging from E cigarettes,
  • 25:10cigars, hookahs,
  • 25:11so these flavors are obviously a
  • 25:13very important issue in attracting
  • 25:14people to to use these products.
  • 25:16Just giving an example of E cigarettes and
  • 25:19I'm taking a little bit of a diversion here,
  • 25:22but just focusing on that 'cause we've
  • 25:24done a lot of work in this area.
  • 25:26This is the flavors in E cigarettes count.
  • 25:29There are over 15,000 flavors and
  • 25:31they have all these very unusual
  • 25:33names that you see here,
  • 25:34like.
  • 25:35Cupcake man an appletini and if
  • 25:37they get even worse than that,
  • 25:39Dragon's blood and so on and so
  • 25:41forth that really bring you to using
  • 25:43and wanting to use these products.
  • 25:45This is data from Bonnie how
  • 25:46confession and her group in Stamford,
  • 25:48who showed that you truly believe that
  • 25:50they are being targeted using these flavors,
  • 25:52and these flavored products.
  • 25:54They do not believe that older adults
  • 25:56have any use for these products
  • 25:57and you can see that very clearly
  • 25:59in something like the cupcake man.
  • 26:01They really believe that flavor
  • 26:03which is called a cupcake man,
  • 26:05is really targeted at younger age.
  • 26:06Populations are perhaps even their age,
  • 26:08but definitely not older populations.
  • 26:10So you truly believe these flavors
  • 26:13and these products are for them.
  • 26:15This is some of our data collected
  • 26:19in Connecticut which shows you
  • 26:21the different flavors.
  • 26:23And again here, this represents.
  • 26:25As I said this over 15,000 flavors,
  • 26:27maybe even more if you mix
  • 26:29and match the flavors.
  • 26:30And there are youth really love
  • 26:32fruit flavors and candy flavors.
  • 26:34Very few like the tobacco flavors.
  • 26:36They actually become even smaller
  • 26:38over the years,
  • 26:39and they also like mint flavors and
  • 26:42some of the other flavors listed here.
  • 26:45Now,
  • 26:45the experimental work that we have
  • 26:47done in our center with Eliquis
  • 26:49going back to the mental issues
  • 26:51I was saying telling you earlier,
  • 26:53has also shown that mental and
  • 26:55illiquid significantly improves
  • 26:56the taste of eliquids,
  • 26:58so if you see the left hand side
  • 27:00figure here even very low levels
  • 27:02of menthol significantly improve
  • 27:03the taste of eliquids and how much
  • 27:06people like eliquids that they're
  • 27:08vaping. And if you look at the right
  • 27:10hand side panel here it shows you that
  • 27:13there is actually an interaction between.
  • 27:15The Mental Joes and nicotine dose.
  • 27:17So if there's a high mental concentration
  • 27:20which is very similar to what you see in
  • 27:23commercial mental mental atede products,
  • 27:25people are more likely to like the
  • 27:27taste of high nicotine concentration.
  • 27:29So essentially this is telling us
  • 27:31that this meant or maybe interacting
  • 27:33with nicotine to actually increase the
  • 27:35appeal of the palatability of eliquids.
  • 27:38And we're showing we're actually
  • 27:40conducting similar tests like this
  • 27:42in with other flavors as well.
  • 27:44In the same study also showed that
  • 27:48mental increased some of what we
  • 27:51would consider in our field as.
  • 27:53Issues being more important for addiction,
  • 27:56so it increases you know liking
  • 27:58wanting the cigarette and it also
  • 28:01improves craving for the cigarettes.
  • 28:03So again,
  • 28:04say telling us that meant only be important,
  • 28:08not just for the initial appetitive
  • 28:10affects but also for how much
  • 28:13people continue to like an crave.
  • 28:15These cigarettes and how much is
  • 28:18related to it may have an influence
  • 28:22on predicted potential.
  • 28:24However,
  • 28:24this story is not so simple because again,
  • 28:28work from RT course has shown that
  • 28:30flavors may also be important
  • 28:32for small for those who smoke who
  • 28:35are trying to quit smoking,
  • 28:37and this is data that was examined
  • 28:40using the path launch general data
  • 28:43that I mentioned earlier by Doctor
  • 28:45Friedman an she shows here that
  • 28:48wild flavors are important for,
  • 28:50you know,
  • 28:51used by youth and also used by
  • 28:53emerging adults from an initiation.
  • 28:56Respective flavors are also important
  • 28:58from a cessation perspective.
  • 28:59For adults who smoke,
  • 29:00and so the question really is the
  • 29:03question that the public health
  • 29:05debate that's going on now is.
  • 29:07How do you regulate use of flavors
  • 29:09in this product where they can
  • 29:12still be beneficial?
  • 29:13Potentially,
  • 29:13if they are beneficial for people
  • 29:15who smoke who are trying to quit
  • 29:18smoking versus how do you regulate
  • 29:20the flavors so you keep keep it,
  • 29:22make it less attractive,
  • 29:24and keep it away from.
  • 29:26So this is these are ongoing experiments
  • 29:28that we are conducting in our centers
  • 29:30and many centers on the FDA is very
  • 29:33interested in the answer to this question,
  • 29:35which we don't have yet, by the way.
  • 29:38So the other issue,
  • 29:40the FDA, as I said,
  • 29:41is interested in his nicotine.
  • 29:43Now most of you know you've
  • 29:45probably heard from other people
  • 29:46in the Department about nicotine
  • 29:48and its importance in the body.
  • 29:50It targets a nicotinic acetylcholine
  • 29:52system and it is the primary addictive
  • 29:54ingredient in tobacco products.
  • 29:55And as I like to tell people when
  • 29:58I'm talking about nicotine and I'm
  • 30:00sure I'm preaching to the choir,
  • 30:02here is nicotine has a lot of
  • 30:04effects and it affects almost
  • 30:06every organ of the human body.
  • 30:08Now,
  • 30:09in an early paper by Benowitz Neal
  • 30:11Benowitz and Jack Henningfield,
  • 30:13they had positive that there might be
  • 30:15a threshold for nicotine addiction,
  • 30:17which is that they might be
  • 30:19a low level of
  • 30:20nicotine, which could be
  • 30:22allowed in cigarettes,
  • 30:23which would make the product addictive.
  • 30:25But if you went below that threshold,
  • 30:27product might not be so addictive,
  • 30:29so there is a lot of
  • 30:31ongoing work in this area.
  • 30:33Loading In at Yale here,
  • 30:35and this is work done by
  • 30:37men and see for glue.
  • 30:39There he is actually using his Ivy
  • 30:42nicotine paradigm and has a very
  • 30:45interesting paradigm where people
  • 30:47administer different nicotine doses
  • 30:50and he uses that information to
  • 30:52determine the threshold that produces
  • 30:55consistent nicotine reinforcement.
  • 30:56And this recent paper from his group shows
  • 31:00that the threshold for producing continuous,
  • 31:03consistent nicotine reinforcement,
  • 31:05as determined by whether
  • 31:07people favor and nicotine.
  • 31:09However,
  • 31:09they favor sailing was about .2
  • 31:11milligrams for 70 kilograms,
  • 31:13so there is evidence emerging that there
  • 31:15might be a threshold that could be
  • 31:18established in some of these products,
  • 31:21and in fact work done by others in the field.
  • 31:24Eric, Tony,
  • 31:25and Dorothy had to call me have
  • 31:27done clinical trials that cigarettes
  • 31:30that have reduced nicotine content.
  • 31:33Let's have reduced the dose to you.
  • 31:35See some of the different doses.
  • 31:37I'm not showing you the different
  • 31:39doses they tried.
  • 31:40Sorry,
  • 31:41they tried a whole bunch of different
  • 31:43doses and they try to see how reducing
  • 31:46the dose of nicotine in a cigarette all turn.
  • 31:49Use behaviors,
  • 31:50quit attempts,
  • 31:51whether it changed.
  • 31:53And other people there was any
  • 31:55compens atory smoking and they found
  • 31:57overall that reducing the dose.
  • 31:592.4 milligrams per gram of tobacco
  • 32:01actually reduced the number of
  • 32:03cigarettes smoked by people,
  • 32:05reduce dependence and resulted
  • 32:06in no compens atory smoking.
  • 32:08In fact,
  • 32:09other groups have shown similar outcomes.
  • 32:11With these reduced nicotine cigarettes
  • 32:13in many vulnerable populations,
  • 32:14including people with psychiatric
  • 32:16conditions as well as youth
  • 32:18and non daily smokers.
  • 32:19So the FDA is very interested in this idea.
  • 32:22The earlier FDA commissioner was
  • 32:24very interested in the idea.
  • 32:26Of moving forward with this idea of
  • 32:29reducing nicotine concentration in
  • 32:30tobacco and in cigarettes rather sorry.
  • 32:32I mean be clear in cigarettes
  • 32:34and Dorothy and Eric have also
  • 32:37shown that the best approach,
  • 32:38the best way to do this might be
  • 32:41by having an immediate reduction
  • 32:43in the level of nicotine.
  • 32:45Instead of having one one of the
  • 32:47things the FDA was considering,
  • 32:49whether they should have a tapered or
  • 32:52a gradual reduction in nicotine levels
  • 32:54in commercially available nicotine.
  • 32:56Levels in commercial cigarettes,
  • 32:58but they've shown that an
  • 33:00immediate approach might be the
  • 33:01best way to achieve this goal,
  • 33:03so this is something that is being
  • 33:06considered by the FDA and they
  • 33:08have not taken action on it yet.
  • 33:10But it seems that they might be starting
  • 33:12to get interested in this issue again,
  • 33:15and so you may see more news articles or more
  • 33:18actions being discussed about this issue.
  • 33:21No, that does nicotine in cigarettes.
  • 33:23Again, what about nicotine
  • 33:24and other tobacco products?
  • 33:26Again,
  • 33:26here we don't have a clear.
  • 33:28We don't have clear direction
  • 33:30because all the work is
  • 33:31only been done with cigarettes
  • 33:33and cigarette as a delivery device
  • 33:35is very different than cigar or E
  • 33:37cigarettes as a delivery device for
  • 33:39nicotine and this is particularly
  • 33:41concerning because E cigarettes like
  • 33:43the secrets that you heard about like
  • 33:45Jewel which are on the market which
  • 33:47are very very popular with the youth
  • 33:49contain what is code word containing
  • 33:51katien solves now nicotine sauce.
  • 33:53Normally, nicotine in most cigarettes
  • 33:55is freebase nicotine which is
  • 33:57irritating to the throat and you
  • 33:59know that's if any of you have smoke.
  • 34:01That's the reason you kind of cough.
  • 34:03Then you take your first love,
  • 34:05but the nicotine salts,
  • 34:06which are in many liquids like
  • 34:08jewel and many of the newer obvious
  • 34:10products contain assault like
  • 34:11nicotine benzoate weight,
  • 34:13which is what you're so shown here.
  • 34:15Now these soles are proposed to be
  • 34:17less harsh and they say that it makes
  • 34:20the product a lot more palatable
  • 34:22and a lot more easier to use.
  • 34:24As a result, some of these products,
  • 34:27like June,
  • 34:28contain very high levels of nicotine.
  • 34:30Juul goes as far as 60 milligrams
  • 34:33of nicotine in the product itself,
  • 34:36which is compares to almost 2
  • 34:39packs of cigarettes,
  • 34:40and this this shows these products are
  • 34:43really marketed very widely and there is,
  • 34:46as I said, you truly love them.
  • 34:49So there is a lot of concern
  • 34:52about what to do about.
  • 34:54These kinds of products and there
  • 34:56is no clear guidance and nuclear
  • 34:58science to support this as yet,
  • 35:00and this is a lot of the work that
  • 35:03we're focusing on in our center.
  • 35:05And not to confuse the issue anymore,
  • 35:07but I just have to tell you that
  • 35:09there is another player in the
  • 35:11market which is synthetic nicotine.
  • 35:13This was just introduced in
  • 35:14the market recently and.
  • 35:16Overall, the FDA,
  • 35:17the family smoking tobacco prevention and
  • 35:19Control Act that I mentioned earlier,
  • 35:22is really directed at nicotine
  • 35:23that comes from tobacco products,
  • 35:25so their authority does not
  • 35:27extend to synthetic nicotine.
  • 35:29So it seems like some people have found
  • 35:31out a way of creating synthetic nicotine,
  • 35:34and now many of these products,
  • 35:36like E cigarettes and the
  • 35:38oral tobacco products,
  • 35:39are using synthetic nicotine in them,
  • 35:42and one of the questions that
  • 35:44we have as a community.
  • 35:46Of researchers and advocates in
  • 35:48this area is are these even can't
  • 35:50even be regulated by the FDA.
  • 35:52So what I'm trying to tell you is
  • 35:54that the industry changes and it
  • 35:56changes depending on what laws are
  • 35:58coming into the market and this is
  • 36:01a battle of heavy fight on a daily
  • 36:03basis and somebody really needs
  • 36:05to address this issue of nicotine
  • 36:07and other products.
  • 36:09So that was so essentially
  • 36:10exactly what I just said.
  • 36:11We need a lot more scientific evidence
  • 36:13to support both flavor and nicotine
  • 36:15regulation issues in tobacco products.
  • 36:17Now I'm going to move on to telling
  • 36:20you a little bit about E cigarettes.
  • 36:23Most of you have seen these products,
  • 36:24I'm sure on the market,
  • 36:25but I'm not sure if you know
  • 36:27the history behind these.
  • 36:28So I thought I would just tell you a
  • 36:30little bit about why we are where we are.
  • 36:33These products were created
  • 36:34with a very good intention.
  • 36:36They were created by Chinese Spanish.
  • 36:38This pharmacist in 2003.
  • 36:39He wanted to be able to provide those
  • 36:42who smoke with a cleaner form of
  • 36:44nicotine to help them quit smoking,
  • 36:47which is a very Noble intention.
  • 36:49The device purses are very
  • 36:50simple devices shown here.
  • 36:52It has a power source.
  • 36:53It has a control button.
  • 36:55There is a there is an illiquid
  • 36:57or a juice which is in a container
  • 37:00and you ignite or heat up the
  • 37:03juice using the power source.
  • 37:05And then it creates a vapor and you,
  • 37:07the individual,
  • 37:08can inhale the vapor through
  • 37:10the mouthpiece that you see on
  • 37:12the extreme right here today.
  • 37:14There are over 400 E cigarette
  • 37:16brands and many,
  • 37:17many different kinds of devices
  • 37:19on the market.
  • 37:20This market has basically developed
  • 37:22unregulated and that is the
  • 37:24unfortunate part of the story when
  • 37:26they first came on into the US,
  • 37:28the US,
  • 37:28the FTA,
  • 37:29wanted to reject the entry of
  • 37:31these devices and classify them
  • 37:33as a drug delivery device because.
  • 37:35That's essentially what they are.
  • 37:37They deliver a drug that can
  • 37:39be used to deliver anything.
  • 37:41But this company called Smoking Everywhere
  • 37:43or later changed their name to enjoy,
  • 37:45had a lawsuit against the FDA,
  • 37:47and they said that these
  • 37:49electronic cigarettes are not
  • 37:51drugs or drug delivery systems.
  • 37:52They're tobacco products.
  • 37:53According to the Family Smoking
  • 37:55Tobacco Prevention and Control Act,
  • 37:57and in December 2010,
  • 37:58the US Court of Appeals ruled
  • 38:00that the FDA can only regulate E
  • 38:02cigarettes as a tobacco product
  • 38:04unless therapeutic claims are made.
  • 38:06This is very important,
  • 38:08so if you look at an E cigarette.
  • 38:11Now that you'll see they never
  • 38:13make any therapeutic claims is
  • 38:14they make a therapeutic claim.
  • 38:16They have to go down the pathway in FDA
  • 38:19that many of us are very familiar with,
  • 38:21but they cannot do that and
  • 38:23therefore they can only be
  • 38:25regulated as a tobacco product.
  • 38:27And yet they are being used by millions
  • 38:29of people who smoke to quit smoking.
  • 38:31So it's it's it's.
  • 38:33It's really an interesting situation.
  • 38:34So what this means is that E
  • 38:36cigarettes were not covered.
  • 38:38I said this for our tobacco product
  • 38:40because there not a drug delivery.
  • 38:42Got it but the family smoking provide
  • 38:45prevent tobacco prevention and Control Act.
  • 38:47Did not cover E cigarettes to 2016.
  • 38:49Therefore,
  • 38:49from 2010 to 2016 they were basically
  • 38:52unregulated and they continue to
  • 38:54stay unregulated because the FDA
  • 38:55is now what the FDA did is they
  • 38:58asked all these companies to submit
  • 39:00applications to them called PMT?
  • 39:01Is that they could review to see what
  • 39:04the constituents of the products were,
  • 39:06what they contained and they had.
  • 39:08They wanted all these applications
  • 39:10submitted to them by September 9th,
  • 39:112020 which was just last year and.
  • 39:14What I understand they have millions
  • 39:16of applications, so I think they will
  • 39:18probably remain unregulated through 2022.
  • 39:19Now this does not mean that there aren't
  • 39:22rules about marketing and sales to you.
  • 39:24Then all those all those law still continue,
  • 39:26but the actual regulation of the product
  • 39:28informing people about what's in them
  • 39:30and whether they are safe or not.
  • 39:32That's something that is not going to happen.
  • 39:34May not happen for a while.
  • 39:36In the meantime,
  • 39:37this is a great market is just exploded.
  • 39:39These are some of the kinds of E
  • 39:42cigarettes you find on the market.
  • 39:44They started out with these
  • 39:45very cigarette like products.
  • 39:46Moved on to things called vape pens,
  • 39:49which basically had the E liquid in
  • 39:51a tank like I showed you earlier.
  • 39:53You have these box mods which are
  • 39:56very very used a lot by people who
  • 39:58use it in for recreational purposes
  • 40:00like producing vape clouds,
  • 40:02and you know participating in
  • 40:03competitions and things like that.
  • 40:05You can really do a good job
  • 40:07adjusting the voltage and the device.
  • 40:09The temperature of the device,
  • 40:11what you put in the device so you
  • 40:14know there are a lot of things
  • 40:16that you can change.
  • 40:18And then there are these newer
  • 40:19devices called Pod devices,
  • 40:21and these are the ones like the
  • 40:23jewel that you see here and then on
  • 40:25the right hand side at the bottom.
  • 40:27Here you see these newest newest
  • 40:29products called Puff Bars which
  • 40:31are very similar to the jewel,
  • 40:32but they are disposable devices that
  • 40:34again contain the nicotine salts.
  • 40:36Like I told you earlier and coming
  • 40:38up variety of flavors which are
  • 40:40very very attractive to you.
  • 40:42This shows you sales of these
  • 40:44products and how it has dramatically
  • 40:46increased over the years.
  • 40:48These are considered to be a very
  • 40:50good product to invest in and
  • 40:52many investors unfortunately and
  • 40:54there is an ongoing debate in the
  • 40:57Community about what are the benefits
  • 40:59versus harms of these products.
  • 41:01Now I'm just trying to present
  • 41:03both sides of it here for you.
  • 41:05The benefits is that if these products
  • 41:08help smokers to quit smoking,
  • 41:10then it would definitely be
  • 41:12reduced disease risk.
  • 41:13For these current smokers,
  • 41:14if they switch to E cigarettes or
  • 41:17reduce or quit test cigarettes,
  • 41:19there would be reduced disease
  • 41:21morbidity for those with heart and lung
  • 41:23disease who switched to E cigarettes.
  • 41:25And we can also think about it from a
  • 41:28psychiatric population condition issue.
  • 41:30You know there there may be changes
  • 41:32even in their disease morbidity
  • 41:34and risks for other diseases.
  • 41:36But there are also harms that
  • 41:38need to be considered,
  • 41:40particularly with relationship to youth,
  • 41:42because these products being.
  • 41:43Expose them to increase concentrations
  • 41:45of nicotine and leave to lead to
  • 41:47nicotine addiction and greater
  • 41:48initiation of conventional tobacco
  • 41:50products and kind of a renormalization
  • 41:52of tobacco use behaviors.
  • 41:53All these years we've been telling you,
  • 41:55cigarettes are bad.
  • 41:56Don't use them and now you have these
  • 41:59products out on the market which are really,
  • 42:02you know, re normalizing this
  • 42:03tobacco use behaviors amongst you.
  • 42:05So this is a big concern.
  • 42:07There's also concern among adults
  • 42:09because many adults unfortunately
  • 42:10are not switching completely over
  • 42:12to E cigarettes but are using them.
  • 42:14For what I call Julie's behavior,
  • 42:16so they smoke when they can,
  • 42:18and if it then they can.
  • 42:20So the concern is is this slowing
  • 42:22sensation by smokers or complete quitting
  • 42:24by smokers and the other concern is
  • 42:26is also leading to a reinitiation of
  • 42:29nicotine addiction and former smokers.
  • 42:30There are many people who have
  • 42:32quit smoking who are now coming
  • 42:34back to using these products.
  • 42:36So you know these are a
  • 42:38lot of concerns that exist.
  • 42:40So let me just walk you through some
  • 42:42of these issues until end something.
  • 42:45Even some things to consider.
  • 42:46So let's consider hormone toxicity now.
  • 42:48This when you compare cigarettes
  • 42:50to E cigarettes.
  • 42:51If you were looking to if you wanted
  • 42:53to do an apples to apples comparison,
  • 42:55which it really isn't.
  • 42:57But if you wanted to look specifically
  • 43:00at select a massive natural.
  • 43:02The Big the bad boys in cigarette
  • 43:05products that cause a lot of cancers.
  • 43:07So if you look at nitrosamine's and
  • 43:09other toxins and you compare cigarettes
  • 43:11to E cigarettes and absolutely without
  • 43:13a doubt the levels of nitrosamine's
  • 43:16is less than cigarette in E cigarettes
  • 43:18when you compare it to cigarettes
  • 43:20suggesting that they probably may have
  • 43:22reduced cancer risk then E cigarettes too.
  • 43:25Although we don't have,
  • 43:26you know the long term studies to show that,
  • 43:29but definitely this data
  • 43:30suggests that they may.
  • 43:32However there are a lot of other
  • 43:34components introduced in a liquid.
  • 43:36That we know very little about and
  • 43:38this list some of those components.
  • 43:41There are some vehicles that are used like
  • 43:43propylene glycol and vegetable cursory.
  • 43:45There are a number of flavors that
  • 43:47constitute all the flavor components.
  • 43:49There are sweeteners and there's nicotine.
  • 43:51And then there's also metals
  • 43:53that come from the coil heating
  • 43:55of the coil in the E cigarette.
  • 43:57So there are other concerns that we have.
  • 44:01I'm going to specifically focus on
  • 44:03flavors for a little bit because this
  • 44:05is a great interest in our center.
  • 44:07It was an ad.
  • 44:10Many people may not know are
  • 44:12not just benign chemicals,
  • 44:13they're actually the.
  • 44:14Each flavor is made up of a number of
  • 44:17different chemicals and this just gives
  • 44:19you a little bit of a flavor of some
  • 44:22of the aldehydes that are contained
  • 44:24in some of these flavored E liquids.
  • 44:26And there is a lot of concern about
  • 44:29exposure to high levels of some of
  • 44:31these aldehydes and what they might do.
  • 44:33Many of these inhaled flavors are
  • 44:35known to have health effects now.
  • 44:37These flavors are commonly used for
  • 44:39a lot of terrible products and.
  • 44:41So in your Cheerios or your flavored
  • 44:43cereals and other flavored products
  • 44:45where they are considered to be grass,
  • 44:47which is generally recognized as
  • 44:49safe but they are not classified
  • 44:50as grass for inhalation.
  • 44:52And that is how they are
  • 44:54being used in this product.
  • 44:55So there's a lot of inhaled health
  • 44:57effects that we still don't understand,
  • 44:59but there is emerging evidence
  • 45:01that flavors can be toxic to
  • 45:03cells as you see in this slide.
  • 45:05These are some of the flavors
  • 45:07listed on the bottom of the slide,
  • 45:09and many of these flavors are comma.
  • 45:11Are aldehydes as can be listed
  • 45:14here and aldehydes are known to be
  • 45:16carcinogenic and it will all depend
  • 45:18on what the level of the flavor is,
  • 45:21how it is being used to.
  • 45:23People heat the product excessively so that
  • 45:26do they inhale more of these aldehydes?
  • 45:28All these concerns that we have
  • 45:30and there are some examples in
  • 45:32the literature of flavors like
  • 45:34diacetyl that increase the risk of
  • 45:36things like popcorn lung disease.
  • 45:38Interestingly,
  • 45:38this was something that was found in
  • 45:41people who were working in buttered.
  • 45:43In popcorn factories where they were
  • 45:45adding butter into the popcorn and
  • 45:47they found that many of these workers
  • 45:49actually had popcorn lung disease,
  • 45:51hence the name.
  • 45:52Now this flavor diacetyl is
  • 45:53included in many flavorings to
  • 45:55produce that buttery flavor.
  • 45:57Again,
  • 45:57this is not.
  • 45:58I'm not saying that all these
  • 46:00things have been shown to happen,
  • 46:02but these are the concerns which are
  • 46:04coming up and it's going to be very
  • 46:06concentration dependent in terms
  • 46:08of what these effects are and these
  • 46:10are things we need to determine.
  • 46:12Our center is also shown that Wendy's.
  • 46:14Unicorns are sitting on a
  • 46:17shelf they actually produce.
  • 46:18They actually result in some common
  • 46:21some chemical transformations I should
  • 46:24say and produce these acetals acetals
  • 46:27are basically aldehydes combined
  • 46:28with some of the the dialogues
  • 46:31that I was talking about earlier,
  • 46:33like propylene glycol and vegetable glycerin,
  • 46:36and these acetals are produced
  • 46:38in the standing illiquid even
  • 46:40before somebody inhales.
  • 46:41These eliquids and data from
  • 46:44our sector also shows that.
  • 46:47At these acetals are actually more
  • 46:49irritating than the parent aldehydes,
  • 46:51and therefore there is concern about
  • 46:53what the presence of these acetals
  • 46:55might do when humans are exposed to it.
  • 46:58So this is again evidence that
  • 47:01needs to be collected.
  • 47:02So obviously we have concerns about toxicity,
  • 47:05and there's a lot of other evidence
  • 47:07coming out about cardiovascular risks
  • 47:09and pulmonary risks related to eliquids
  • 47:12that I'm not going to be talking about,
  • 47:15but there is.
  • 47:16Emerging evidence on this issue.
  • 47:18So based on that,
  • 47:19the National Academy of Science
  • 47:21report in 2019 put out the
  • 47:23statement which basically said that
  • 47:25E cigarettes are not risk free.
  • 47:27They suggest if the current evidence
  • 47:29suggests that it's far less harmful
  • 47:31than combustible tobacco cigarettes,
  • 47:33but we still need a lot more data
  • 47:35to assess risk of these products
  • 47:38from morbidity perspective.
  • 47:40Now coming back to this slide
  • 47:42that I showed you earlier,
  • 47:43as I told you,
  • 47:44one of the biggest discussions in
  • 47:46the field is the balance of benefits
  • 47:48versus cons for smokers versus youth.
  • 47:51And let me show you some of
  • 47:53the evidence on
  • 47:54that. Now in as the rates of these use
  • 47:56of these products have been growing used
  • 47:58by you testing growing dramatically,
  • 48:00national data collected about use
  • 48:02of E cigarettes amongst youth in
  • 48:04the United States and this red line
  • 48:06shows you how the rates that the
  • 48:08cigarette use has gone up dramatically.
  • 48:10And how they continue to rise?
  • 48:12They experienced a little bit
  • 48:14of a dip last year,
  • 48:15but still they're not back down to,
  • 48:18you know, very low levels.
  • 48:19They're still at what was seen in 2018.
  • 48:22There's a similar data and
  • 48:24middle school students,
  • 48:25and we actually get calls from even
  • 48:27students who are younger than that
  • 48:29from schools telling us that they have
  • 48:31caught students with these products in
  • 48:33their backpack or using these products.
  • 48:36E Cigarettes are the first product
  • 48:38tobacco product used by most youth today.
  • 48:40This is data we collected in Connecticut.
  • 48:42Really asked the youth what is
  • 48:44the first tobacco product you used
  • 48:46and you can see that almost 70%
  • 48:48of them said the first tobacco
  • 48:50product they used was E cigarettes.
  • 48:52So this is very concerning.
  • 48:53You also use multiple devices.
  • 48:55I showed all the devices earlier that
  • 48:57there are many different types of devices.
  • 48:59We have found that you'd use
  • 49:01whatever devices available to them.
  • 49:02They may use a friends device,
  • 49:04they use their own device but they use.
  • 49:07Of all the devices that are available
  • 49:09and their use behavior changes as
  • 49:11new devices come into the market and
  • 49:13that is something that we have really
  • 49:15struggled to keep up with because we
  • 49:18have to constantly keep introducing
  • 49:20new terms and assessing the use
  • 49:22of new devices in the surveys that
  • 49:24we do with youth in high schools.
  • 49:27You don't sound really like and this
  • 49:29speaks to the addiction issue or the
  • 49:32electric potential of these products.
  • 49:34In a survey that we did when in
  • 49:36Connecticut high schools students,
  • 49:38we found that they most people among the
  • 49:41youth who used E cigarettes or juuls.
  • 49:43In this case they said that they
  • 49:45really like the buzz or the kind of
  • 49:48stimulating effect they were getting
  • 49:50from these products and this is
  • 49:52concerning because if you look at
  • 49:54these two groups, the Blue Group.
  • 49:56Are non current jewel users which
  • 49:58means people who kids who use Juul
  • 50:00in the past but had not currently
  • 50:03using and these are current Julie
  • 50:05users and there is a significant
  • 50:07difference between the two groups
  • 50:09and that the noncurrent Juul users
  • 50:10say they did not like the they did
  • 50:13not like the buzz in jewels as much
  • 50:15as the current Juul users too.
  • 50:17So the question really is are these
  • 50:19this continuation of behavior that
  • 50:21you see in the current users?
  • 50:23Is it related to the fact that they
  • 50:25like this plus or the stimulating
  • 50:27effects from nicotine?
  • 50:29And again some other things to
  • 50:31point out on these slides.
  • 50:32Also,
  • 50:33is that your thoughts are really
  • 50:35like these Juul products for flavors,
  • 50:37and because their friends use it,
  • 50:39these are in fact some of the top
  • 50:42three issues that came out as why
  • 50:45you'd like these products now.
  • 50:47Further evidence from that same paper
  • 50:49showed that the these pharmacological
  • 50:50effects that I showed you earlier.
  • 50:53Like you know, these ability
  • 50:55changing ability to concentrate,
  • 50:56feeling more energetic.
  • 50:57All these effects and the product
  • 51:00characteristics like liking the size.
  • 51:01Making the shape these were
  • 51:03related to frequency of Julius,
  • 51:06so the the more they like the.
  • 51:10Logical effects of product characteristics.
  • 51:12The more likely they were too.
  • 51:16Interesting Lee pure influences
  • 51:17was negatively related,
  • 51:18so our thinking on this is that perhaps
  • 51:20peer influences are more important
  • 51:22for initiation of use of this product.
  • 51:24But once they have developed
  • 51:26a regular use behavior,
  • 51:27it's more the pharmacological
  • 51:28effects and other effects which
  • 51:30really maintain these behaviors.
  • 51:31So again, you can see this is moving
  • 51:33along the addiction area here,
  • 51:35and we worry a lot about
  • 51:38nicotine use and you because.
  • 51:40Indian Ocean brain it's times
  • 51:42of rain for addiction it onto a
  • 51:44settlement of insuring it changes,
  • 51:46learning memory and attention.
  • 51:47In fact,
  • 51:48the earlier surgeon General had
  • 51:50actually labeled one of our earlier.
  • 51:52Sorry if the Commissioners
  • 51:53and actually labeled nicotine
  • 51:55addiction as a pediatric disease
  • 51:57because he said that if you get
  • 51:59addicted prior to the age of 18,
  • 52:01you have worse health outcomes,
  • 52:02more dependence and a harder time quitting.
  • 52:05So we have a lot of concerns about you.
  • 52:08Queues of such high levels of nicotine's.
  • 52:10What you see in jewel on these
  • 52:12other products you are also using
  • 52:14these products for other behaviors.
  • 52:16They use them for vape tricks,
  • 52:18they can easily adapt these products
  • 52:20to do produce different vape clouds
  • 52:22like you see here and they they
  • 52:24participate in weight competitions.
  • 52:26They use it for behaviors like dripping,
  • 52:28which basically means opening up
  • 52:30the device and dropping the liquid
  • 52:32directly on the heated coil in
  • 52:34inhaling it and they are now starting
  • 52:37to use it for vaping cannabis
  • 52:38to the cannabis story is very
  • 52:40interesting because they use cannabis.
  • 52:42Devices and then they also hack
  • 52:44E cigarette devices to introduce
  • 52:46cannabis into it.
  • 52:47So these presence of these devices
  • 52:49is introducing you to a variety
  • 52:51of these other behaviors that we
  • 52:54know very little about the risk of.
  • 52:56And our daughter centers also
  • 52:58shown that E cigarette use also
  • 53:00leads to cigarette use.
  • 53:01This is using longitudinal data
  • 53:03that we collected in Connecticut.
  • 53:05We showed that youth who started with
  • 53:08the cigarettes were more likely to
  • 53:10move onto cigarettes in the future.
  • 53:13So we have a lot of concerns
  • 53:15that I highlighted very quickly
  • 53:16for you amongst youth.
  • 53:18What about smoking cessation?
  • 53:19You know the other aspect of it is,
  • 53:21is there evidence on whether these
  • 53:24products or smoking cessation?
  • 53:25So 2016 contribution.
  • 53:29By that time,
  • 53:30a very small sentence with limited samples.
  • 53:33And you basically said that they
  • 53:34probably help people smoking stop
  • 53:36smoking and they probably work
  • 53:38better than nicotine replacement
  • 53:39therapy and nicotine free cigarettes.
  • 53:41But you see that use the word probably
  • 53:44in May a lot in this in this review,
  • 53:47essentially suggesting that more
  • 53:48reliable evidence was needed.
  • 53:49But if you talk to smokers,
  • 53:51there are multiple observation.
  • 53:53ULL studies in which people will tell
  • 53:56you that I quit using 60 cigarettes
  • 53:58and I have no doubt that they did.
  • 54:00But the clinical trial evidence
  • 54:02is still emerging on this issue.
  • 54:04In fact,
  • 54:05they were trying to bring some
  • 54:07clinical trials that came out,
  • 54:09one by teacher hike which looked
  • 54:11at which look very
  • 54:12promising. This one compared E
  • 54:15cigarettes to nicotine replacement
  • 54:17therapy and found that people who
  • 54:19use E cigarettes actually did
  • 54:21better than those who got in RT at.
  • 54:23Interestingly, he also found
  • 54:24that the respiratory symptoms,
  • 54:26relative risk of respiratory symptoms
  • 54:28like shortness of breath, wheezing,
  • 54:30caused all that was reduced in people who
  • 54:33use E cigarettes versus those who use NRT.
  • 54:36And this is a movie flyer by Natalie
  • 54:39Walker from New Zealand that again
  • 54:41compared combining nicotine Patch
  • 54:43with E cigarettes that either contain
  • 54:46nicotine or did not contain nicotine.
  • 54:49And she found that combining these
  • 54:51nicotine Patch with the cigarettes
  • 54:53that contain nicotine actually
  • 54:55had greater benefits and repent.
  • 54:58Increased produced better quit rates
  • 55:00during follow up then having the
  • 55:03circus that did not contain nicotine.
  • 55:05So just to summarize very briefly.
  • 55:08There is a concern about impact on you.
  • 55:11That huge concern because youth
  • 55:13and young adults and this is a
  • 55:15summary from the National Academy of
  • 55:17Science report that youth and young
  • 55:19adults may be more likely to use
  • 55:21these products and try cigarettes.
  • 55:23And there is a big concern
  • 55:25about nicotine exposure.
  • 55:26There is emerging limited evidence that E
  • 55:28cigarettes may help people stop smoking,
  • 55:30but and you know really the goal
  • 55:32should be for complete switching from
  • 55:35cigarettes to E cigarettes and that goal
  • 55:38is if you can achieve that goal then.
  • 55:40You can definitely reduce exposure
  • 55:42to a number of toxic toxin toxicants
  • 55:45and carcinogens found in cigarettes.
  • 55:47There are some moves considering
  • 55:50which are considering how to regulate
  • 55:52E cigarettes so they can remain
  • 55:55beneficial for smokers,
  • 55:56smokers and yet reduce attractiveness
  • 55:59for you.
  • 56:00Then some of these being considered
  • 56:02things like regulating nicotine levels.
  • 56:04The EU for example only allows 20
  • 56:08milligrams of nicotine in there.
  • 56:11Products as I told you,
  • 56:13Juul contains up to 60 but the concern
  • 56:15is that maybe smokers may need higher
  • 56:17levels of nicotine to quit smoking.
  • 56:20There is some consideration of removing
  • 56:22all flavors in eliquids like Canada has,
  • 56:24but then there is a concern.
  • 56:26Like I told you that smokers may
  • 56:28need flavors to quit smoking.
  • 56:30And there is some move towards regulating
  • 56:32the kinds of devices available.
  • 56:34So these are all things that we're
  • 56:37generating scientific evidence for in
  • 56:39our center and in the other centers.
  • 56:41Well,
  • 56:41there are a lot of ongoing regulations
  • 56:43and these are my last few slides.
  • 56:45I promise there are a lot of regulations
  • 56:48that have been applied to these
  • 56:50products to potentially reduce their
  • 56:52use by youth and we are doing a lot of
  • 56:55education of students, parents and teachers.
  • 56:57I think we have.
  • 56:58My group has gone to over
  • 56:59100 schools in Connecticut,
  • 57:01educating students,
  • 57:02parents and teachers and Trisha
  • 57:04Doll whom many of you know very
  • 57:06well is very closely involved in
  • 57:07these efforts to make sure that they
  • 57:10understand the risks of these products.
  • 57:12And we're also through this American
  • 57:14Heart Association funded center,
  • 57:15developing both prevention and
  • 57:16individual cessation programs,
  • 57:17which I don't have time to tell
  • 57:19you about right
  • 57:20now, but hopefully at some point in the
  • 57:23future, once we have more evidence,
  • 57:25I'll be telling you more able to tell
  • 57:28you more about how these efforts pan out.
  • 57:31Now my very last slide is.
  • 57:33What can you do?
  • 57:34You heard me talk a lot about all
  • 57:36these products and present some of
  • 57:38the nuances and conflicts to you.
  • 57:41I would say as clinicians you should continue
  • 57:43to encourage your patients to quit smoking.
  • 57:46Quitting combustible cigarettes use is
  • 57:48probably the best thing anybody can do.
  • 57:51Or to improve their help,
  • 57:53encourage them to use treatments
  • 57:54that have been shown to work that
  • 57:56that is good scientific evidence
  • 57:58for like behavioral interventions,
  • 58:00like pharmacological interventions
  • 58:01that are available,
  • 58:02like NRT and appropriate on an Chantix.
  • 58:04But if nothing else works on your
  • 58:06patient wants to use these cigarettes,
  • 58:09then I would support them.
  • 58:10But you know,
  • 58:11warn them not to over use the E cigarettes,
  • 58:14use it as they would their cigarettes.
  • 58:17Encourage them to put cigarettes completely,
  • 58:19none.
  • 58:19None of this dual use behavior
  • 58:21because that's going to be.
  • 58:23You know,
  • 58:23even could get them exposed to
  • 58:25even more nicotine than they.
  • 58:27Then they are normally used to being
  • 58:30exposed to and encourage them to come
  • 58:32up with a plan to quit cigarettes as well.
  • 58:35I would also encourage you
  • 58:37to educate your patients,
  • 58:38educate communities and local schools,
  • 58:40other community organizations,
  • 58:41and Lastly help us collect
  • 58:43scientific evidence on E cigarettes.
  • 58:45The we needed.
  • 58:46The FDA needs it to really regulate
  • 58:48these products well.
  • 58:50And I will stop there and I have.
  • 58:52I know I presented a lot of
  • 58:54information to you,
  • 58:55but I'm happy to answer any
  • 58:56questions that you might have.
  • 59:11So people can either put their questions
  • 59:13in chat or you can just ask her out loud.
  • 59:19Do you want me to just look at the chat?
  • 59:21Trisha? No question there yet but
  • 59:25chat yet, but but certainly I'm happy
  • 59:27to help moderate as well.
  • 59:29If you need an eye on the chat while
  • 59:31you're asking while you're answering
  • 59:33questions, thank you, Marina.
  • 59:36I did have a quick question Suchitra
  • 59:39and that was around tobacco flavor and
  • 59:42I know that early on you did a study
  • 59:46where you showed that youth with Berry
  • 59:49that you showed that you really don't
  • 59:51like tobacco flavored E cigarettes.
  • 59:54And if I remember from that study,
  • 59:57independent smokers didn't mind it.
  • 60:00And I wondered if you could comment on
  • 01:00:03whether tobacco flavored E cigarettes
  • 01:00:05might be a good compromise between
  • 01:00:08the smoking cessation advantages
  • 01:00:09and the likelihood of youth uptake.
  • 01:00:12So the
  • 01:00:14thing I would say about that is
  • 01:00:16honestly the the in the in some of
  • 01:00:19the studies initial studies we did.
  • 01:00:21We did nobody like tobacco flavored
  • 01:00:23E cigarettes and the reason being
  • 01:00:25that they all said that the tobacco
  • 01:00:28flavors was nothing like the
  • 01:00:29flavor they get in cigarettes.
  • 01:00:31But this this is become quite
  • 01:00:33sophisticated overtime and we haven't
  • 01:00:35looked at some of the newer flavors,
  • 01:00:38but there are now flavors which say they
  • 01:00:40match exactly with Marlboro cigarettes.
  • 01:00:42So they match exactly with certain.
  • 01:00:45Flavors that you get because as you know,
  • 01:00:47most of these tobacco products vary a lot
  • 01:00:49in flavor of the tobacco because of how
  • 01:00:51they're processed and where they come from.
  • 01:00:54I got, I talked to a tobacco farmer once,
  • 01:00:56who gave me a whole history of Burling,
  • 01:00:59tobacco, and how it's processed
  • 01:01:00and where it comes from,
  • 01:01:01which was fascinating.
  • 01:01:02So I think they're doing a better
  • 01:01:04effort of matching these flavors,
  • 01:01:06and I can't answer that question today
  • 01:01:08like I don't know how it would be
  • 01:01:10approached today or how they would like it,
  • 01:01:13but you definitely don't like them.
  • 01:01:15That's for sure.
  • 01:01:15I don't know about the adult smokers.
  • 01:01:19There is a question in the chat from
  • 01:01:22Schuber Rodriguez who says is anyone
  • 01:01:24studying evidence for decreased lung
  • 01:01:26disease morbidity with E cigarettes?
  • 01:01:29Yes, there are many many center
  • 01:01:31studying is that in fact we're doing
  • 01:01:34some studies along those lines.
  • 01:01:36Also to try to look at some
  • 01:01:39biomarkers which might potentially
  • 01:01:40be reflective of lung health.
  • 01:01:43There are other centers
  • 01:01:45doing studies of biomarkers,
  • 01:01:46reflective of of cardiovascular health also.
  • 01:01:49That I'm trying to understand
  • 01:01:51both in people in smokers.
  • 01:01:53What happens when they explain their they
  • 01:01:55completely change over to E cigarettes
  • 01:01:57and then also what happens to some
  • 01:02:00of these biomarkers when you finish,
  • 01:02:02she ate so there's both kinds of
  • 01:02:04studies ongoing and there is.
  • 01:02:06There are some studies which suggest
  • 01:02:08there is there are long changes both
  • 01:02:11in terms of pathology as well as
  • 01:02:13some of the inflammatory pathways
  • 01:02:15which are activated in the line.
  • 01:02:17And there are other studies
  • 01:02:19which suggest that.
  • 01:02:20That is not the case,
  • 01:02:22so again,
  • 01:02:23emerging story.
  • 01:02:25Lots of questions in the chat now.
  • 01:02:28I'll keep going for for our chatters.
  • 01:02:31Zach Carbonek asks what are your thoughts
  • 01:02:33on the potential cardiorespiratory
  • 01:02:34downsides of higher dose nicotine via
  • 01:02:37eproducts compared to the carcinogens?
  • 01:02:39Plus nicotine with traditional cigarettes?
  • 01:02:41So there's a lot of concern about
  • 01:02:44that. One of the T cores that is,
  • 01:02:47that is our sister T course is
  • 01:02:49the Americas that equals from
  • 01:02:51the American Heart Association.
  • 01:02:53And they're actually looking at.
  • 01:02:56Markers like endothelial dysfunction,
  • 01:02:57which is, you know,
  • 01:02:59something that is can be changed
  • 01:03:01with immediate exposure as well
  • 01:03:03as changes in blood pressure.
  • 01:03:05And they showed you that figure that
  • 01:03:07nicotine alters a variety of organ
  • 01:03:09systems and there is evidence emerging
  • 01:03:11that things like endothelial function is
  • 01:03:13altered by exposure to high nicotine levels.
  • 01:03:16Again, as I said,
  • 01:03:18it all depends on how much
  • 01:03:20nicotine you're exposed to.
  • 01:03:21That is why they are considering reducing the
  • 01:03:24nicotine levels in products like Juul, which.
  • 01:03:27In my mind contain an unbelievable
  • 01:03:29amount of nicotine to lower levels,
  • 01:03:32so maybe that effect might also be less.
  • 01:03:43I think Marina
  • 01:03:44froze. I think social Doctor Tech wants
  • 01:03:47some more information about nicotine salts.
  • 01:03:52Nicotine salts check.
  • 01:03:53I'm happy to talk to you about this,
  • 01:03:56but nicotine salts are very
  • 01:03:58interesting and there are probably
  • 01:04:00other people in our center were better
  • 01:04:03at this who can give you better
  • 01:04:06information like I know and sairam,
  • 01:04:08but the nicotine salts toxicity is
  • 01:04:11something that is still emerging
  • 01:04:13and we know that Nick people who
  • 01:04:16use nicotine salts say it's a lot
  • 01:04:19less irritating to the throat.
  • 01:04:21And therefore it makes use of
  • 01:04:23these high levels of nicotine
  • 01:04:25products like Juul much easier.
  • 01:04:28That's really all the information
  • 01:04:29I have right now,
  • 01:04:31but I can connect with you later
  • 01:04:33and maybe give you direct you to
  • 01:04:35some more papers on this issue.
  • 01:04:39Doctor Berger wants to know with low
  • 01:04:41smoking rates, any comments on effects
  • 01:04:44of taxation and the politics of this.
  • 01:04:48Specifically related related to
  • 01:04:50smoking or related to vaping.
  • 01:04:55If you could clarify
  • 01:04:57Doctor Berger, you can
  • 01:04:58unmute yeah on either one
  • 01:05:00so taxation has been used a lot in in
  • 01:05:03smoking as you know to really and in
  • 01:05:06fact that was one of the issues that
  • 01:05:09came up in the menthol cigarette issue
  • 01:05:11I was explaining to you earlier that
  • 01:05:13Connecticut was considering potentially
  • 01:05:15regulating menthol cigarettes and removing
  • 01:05:17menthol cigarettes from the market.
  • 01:05:18I understand one of the big issues that
  • 01:05:21came up in the debate at that point was
  • 01:05:24that the state gets an amazing amount of
  • 01:05:27income from taxation of these products.
  • 01:05:29Millions of dollars and
  • 01:05:31the question really was,
  • 01:05:32can we do this at this point or not?
  • 01:05:35Can we afford to take the financial
  • 01:05:37burden of removing these products on
  • 01:05:39the market so it's a conversation
  • 01:05:41that continues and taxation has a
  • 01:05:43huge influence on that conversation?
  • 01:05:45Taxation also has had has been
  • 01:05:47shown to have a huge influence on
  • 01:05:49youth use of cigarettes,
  • 01:05:51so you the very sensitive
  • 01:05:53very price sensitive.
  • 01:05:54So if the prices of cigarettes
  • 01:05:56go up you QS goes down.
  • 01:05:58Now that model could be applied
  • 01:06:00to E cigarettes also but that.
  • 01:06:02That move has not happened because
  • 01:06:04the concern is again of being
  • 01:06:06able to provide these products for
  • 01:06:08smokers who want to quit smoking,
  • 01:06:10but so the concern is if you start
  • 01:06:12taxing those products too much
  • 01:06:14then smokers will not use them.
  • 01:06:16So you know this debate is ongoing there.
  • 01:06:18I hope that answered your question.
  • 01:06:22It helps, thank you.
  • 01:06:29Anything else, sorry I can
  • 01:06:30see. I'm going West into Trisha
  • 01:06:32'cause all my my chats disappeared.
  • 01:06:34OK, it's all good.
  • 01:06:37Prior to Covid, there were a
  • 01:06:38number of young adults suffering
  • 01:06:40respiratory failure and lung damage,
  • 01:06:43which appeared to be caused from an
  • 01:06:45ingredient in the vape capsules.
  • 01:06:47Has there been any follow up
  • 01:06:49studies on this?
  • 01:06:50Yes, you're referring to a Valley
  • 01:06:53which was can never remember
  • 01:06:55the full what it they give you.
  • 01:06:57These acronyms for everything?
  • 01:06:59If Allie was was seen in the US
  • 01:07:02population primarily at I mean at least
  • 01:07:04wasn't reported from anywhere else.
  • 01:07:06Besides primarily in youth
  • 01:07:08and young adults in the US,
  • 01:07:10and it was the CDC's last word.
  • 01:07:13On this has been that it is
  • 01:07:15potentially related to the use of
  • 01:07:18a product called vitamin E acetate,
  • 01:07:20which is a solvent that is used in in,
  • 01:07:23not commercial supposedly,
  • 01:07:24but black market cannabis products.
  • 01:07:26So the so, as I told you,
  • 01:07:29there is a lot of intersection between
  • 01:07:31cannabis vaping and nicotine vaping,
  • 01:07:33and supposedly there was a
  • 01:07:35solvent called vitamin E acetate.
  • 01:07:37In black market cannabis products,
  • 01:07:39which has been identified as being
  • 01:07:41responsible for the value that said,
  • 01:07:44I don't think the book is closed
  • 01:07:46on that issue yet.
  • 01:07:48Covid just has changed the
  • 01:07:50attention from the Valley to Covid.
  • 01:07:52I understand from a lot of investigators.
  • 01:07:54In fact there is in our group,
  • 01:07:57Steve Baldassarre is doing this work,
  • 01:07:59continuing to examine cases of
  • 01:08:02Valley and how it relates to E
  • 01:08:05cigarette use in the ER at Yale so.
  • 01:08:07There is concern about this and it
  • 01:08:10just has dropped off the CDC's radar
  • 01:08:13because coding became the and rightfully so.
  • 01:08:16An important issue.
  • 01:08:19Alright, Kristen would like to know
  • 01:08:21what would you say in response to the
  • 01:08:23concerns about loss of revenue that
  • 01:08:25might be causing hesitation or pushback
  • 01:08:27on the menthol cigarette ban issue,
  • 01:08:30and what can we do as scientists
  • 01:08:32to advance and support this. So
  • 01:08:35these are all hypothetical situations, right?
  • 01:08:37So there is mental was banned in Canada.
  • 01:08:40I think we need to look at the
  • 01:08:43science and see what happened.
  • 01:08:45There are instances where
  • 01:08:46mental has been banned.
  • 01:08:48We can learn from those what happened there.
  • 01:08:51I think there is no just showing
  • 01:08:53that the impact of a mental balance
  • 01:08:55cigarettes is not as enormous as
  • 01:08:58most people are contemplating.
  • 01:09:00That is going to be there is a
  • 01:09:02recent paper that just came out
  • 01:09:05in 2021 where they model this.
  • 01:09:07Issue and I forget what data they used,
  • 01:09:10but it was based on data that
  • 01:09:12was collected in Minnesota.
  • 01:09:14I think in one County and there's
  • 01:09:16also data from the Canada ban showing
  • 01:09:19that this is not really an issue.
  • 01:09:21I really feel as a scientist that banning
  • 01:09:24menthol in cigarettes as I said earlier,
  • 01:09:27is a social justice issue
  • 01:09:28and it should happen because
  • 01:09:30particular communities like Youth,
  • 01:09:32an African Americans were targeted
  • 01:09:34with these products and there was
  • 01:09:36increasing use of these products.
  • 01:09:38Among those communities and we need
  • 01:09:40to remove mental from cigarettes
  • 01:09:42so we can help these communities.
  • 01:09:47We have great cover on an he says the
  • 01:09:50purchase age was recently increased 21
  • 01:09:53years old in Connecticut and nationally.
  • 01:09:55What effect is this having on initiation?
  • 01:09:59Good question. Unfortunately I
  • 01:10:01can't answer that right now.
  • 01:10:03The reason being that all our our
  • 01:10:05abilities to do surveys and collect
  • 01:10:07all this data over the past year
  • 01:10:09after the Tobacco 21 law passed was
  • 01:10:12significantly affected by covid.
  • 01:10:14So both national surveys and local
  • 01:10:16surveys have been, you know,
  • 01:10:18have had really have been stopped because
  • 01:10:20we haven't been able to collect the
  • 01:10:23data because schools were not in session.
  • 01:10:25You know, how do you collect the data?
  • 01:10:28I'm sure there's somebody
  • 01:10:30collecting data on this.
  • 01:10:31And we will see that pretty soon,
  • 01:10:33but I don't have an answer for you right now.
  • 01:10:35But you know,
  • 01:10:36keep your eyes on the literature.
  • 01:10:37I'm sure there will be
  • 01:10:38something that come out.
  • 01:10:42That is all in chat and less
  • 01:10:44somebody else has a question that
  • 01:10:46they'd like to ask out loud.
  • 01:10:53Hi, can I ask a question course?
  • 01:10:55I think so. Hey, this is Andrew Weinstein.
  • 01:10:58I'm I'm calling via phone as I walk
  • 01:11:01an amazing presentation. Thank you.
  • 01:11:03I was wondering and I joined a
  • 01:11:05little bit early so you might have a
  • 01:11:08justice are is there any increase in
  • 01:11:10gastrointestinal problems as related
  • 01:11:12to E cigarettes and then also are we
  • 01:11:15seeing or is it too early yet to see?
  • 01:11:18Are there other sorts of cancers that are?
  • 01:11:21Typically associated with smoking tobacco
  • 01:11:24that we're seeing with E cigarette.
  • 01:11:28So
  • 01:11:28gastrointestinal issues I
  • 01:11:29cannot answer that, Andrew.
  • 01:11:31I'm sure there's data on this,
  • 01:11:33but I'm not familiar with it.
  • 01:11:35My apologies.
  • 01:11:36I know nicotine has GI effects,
  • 01:11:38so I don't know if there is anything
  • 01:11:40that has been shown directly
  • 01:11:42about that as far as cancers.
  • 01:11:44I think it's going to take a little
  • 01:11:47while longer because you know,
  • 01:11:49I'll remind you that there is an actual
  • 01:11:51graph that shows that lung cancer
  • 01:11:53rates in the US followed the cigarette
  • 01:11:56epidemic or the rise and cigarettes.
  • 01:11:58Used by about 10 years.
  • 01:12:00I'm hoping we you know that
  • 01:12:02we don't get to that point,
  • 01:12:04but you know it takes awhile for cancer
  • 01:12:06change effects to actually show up with it.
  • 01:12:09So it will take awhile with E cigarettes.
  • 01:12:11That said,
  • 01:12:12at my Marina can correct me on this.
  • 01:12:15I don't think there is so I don't know
  • 01:12:17if how much evidence there is on direct
  • 01:12:20effects of nicotine on cancer processes.
  • 01:12:22I think that is literature that
  • 01:12:24is still very small and still
  • 01:12:26emerging and I'm not sure there's
  • 01:12:28any good direction there so.
  • 01:12:30Nicotine person causing cancer
  • 01:12:31is something that I don't know
  • 01:12:33that we know enough about yet.
  • 01:12:34So sorry,
  • 01:12:35that's I think we'll have to
  • 01:12:37wait a couple of years to see
  • 01:12:39what the evidence shows on that.
  • 01:12:41Thank you Ann. Actually,
  • 01:12:43in terms of the gastrointestinal piece,
  • 01:12:45I was wondering if there's a
  • 01:12:46difference for disposable devices
  • 01:12:48versus devices that are reused.
  • 01:12:49Because I'm thinking if they're reused
  • 01:12:51and they're not cleaned up, what?
  • 01:12:53What sort of bacteria is going on?
  • 01:12:55You may not have the answer,
  • 01:12:57but I was curious about
  • 01:12:59that. Yeah, I don't have the
  • 01:13:01answer for that. I'm sorry.
  • 01:13:02I do know that devices that are shared
  • 01:13:05like devices like hookers that are
  • 01:13:07shared are associated with greater rates
  • 01:13:09of infections and I would assume if
  • 01:13:11these devices are shared across people.
  • 01:13:13That same issue would apply,
  • 01:13:14but I don't have direct evidence of that.
  • 01:13:23Can I think we are?
  • 01:13:25I don't see any other questions.
  • 01:13:29Good.
  • 01:13:31Wonderful presentation and discussion. Toxic
  • 01:13:33chitrik. Thank you so much. Thank
  • 01:13:35you, thank you for inviting me
  • 01:13:37and for the great questions.